Detail akcie Alliance Pharma online

Business Summary: Alliance Pharma plc is a United Kingdom-based consumer healthcare company. The principal activity of the Company is to act as a holding company. The principal activity of the Company is the acquisition, marketing and distribution of consumer healthcare and pharmaceutical products. The Company's segments are strategic business units that represent different parts of the overall product portfolio, these being Consumer Healthcare brands and Prescription Medicines. Its Consumer Healthcare brands include Kelo-Cote franchise, Amberen, Nizoral, MacuShield, Aloclair, Vamousse, and other consumer healthcare brands. Its Prescription Medicines include Hydromol, Flamma Franchise, Forceval and other prescription medicines. Its products include Aloclair Plus Gel, Changmin, Fazol Cream, Hydromol Ointment, Kelo-Stretch Cream, and others. It holds the marketing rights to around 80 Consumer Healthcare brands and Prescription Medicines, which are sold around the world in more than 100 countries.
Financial Summary: BRIEF: For the six months ended 30 June 2023, Alliance Pharma plc revenues increased 3% to L81.4M. Net income decreased 61% to L5.1M. Revenues reflect Asia Pacific and china segment increase of 22% to L30M, Americas segment increase of 8% to L14.8M. Net income was offset by Net exchange gain decrease from L1.9M (income) to L1.4M (expense), On loans and overdrafts increase from L1.7M to L4.2M (expense).